[Frontiers in Bioscience 14, 2130-2148, January 1, 2009]

Na,K-ATPase and epithelial tight junctions

Sigrid A. Rajasekaran, Ayyappan K. Rajasekaran

Nemours Center for Childhood Cancer Research, Alfred I. DuPont Hospital for Children, Wilmington, DE 19803

TABLE OF CONTENTS

1. Abstract
2. Introduction
3. Tight junctions
4. Na,K-ATPase
4.1. Functions, subunits and isoforms
4.2. Regulation and interaction with other proteins
4.3. Na,K-ATPase as a signaling molecule
5. Na,K-ATPase and tight junctions
6. Na,K-ATPase in the development of tight junctions
6.1. Na,K-ATPase in blastocyst development
6.2. Na,K-ATPase in zebrafish
6.3. Drosophila and septate junctions
7. Future Perspectives
7.1. Na,K-ATPase, a member of the tight junction protein complex
7.2. Na,K-ATPase b-subunit, a cell adhesion molecule
7.3. Na,K-ATPase, a signaling scaffold that regulates tight junctions
8. Sodium/ion homeostasis and tight junctions
9. A role for Na,K-ATPase in epithelial-mesenchymal transition (EMT) and cancer
10. Conclusions
11. Acknowledgements
12. References

1. ABSTRACT

Tight junctions are unique organelles in polarized epithelial and endothelial cells that regulate the flow of solutes and ions across the epithelial barrier. The structure and functions of tight junctions are regulated by a wide variety of signaling and molecular mechanisms. Several recent studies in mammals, drosophila, and zebrafish reported a new role for Na,K-ATPase, a well-studied ion transporter, in the modulation of tight junction development, permeability, and polarity. In this review, we have attempted to compile these new reports and suggest a model for a conserved role of Na,K-ATPase in the regulation of tight junction structure and functions.

2. INTRODUCTION

Epithelial and endothelial cells line the surfaces in many organs to form the barrier between distinct compartments with defined but different fluid compositions. The transport of water, ions and other solutes across the epithelial barrier is a highly regulated process and occurs via the paracellular and transcellular pathways. Occluding junctions, such as the vertebrate tight junctions (TJs) and the invertebrate septate junctions (SJs), limit free diffusion of the paracellular pathway and function as permeability barriers by sealing the paracellular space between cells. As such, they allow for the regulated water and solute exchange between the compartments in response to appropriate stimuli. Transcellular transport processes involve the channels and transporters in the apical and basolateral plasma membrane of epithelial cells. Na,K-ATPase generates the transepithelial electrochemical and osmotic gradients that drive the passive movement of solutes and has been linked to many cellular transport processes. While the coupling between the paracellular and transcellular transport processes by the Na,K-ATPase through the generation of ion gradients is evident, recent research suggests that Na,K-ATPase plays a more fundamental role in regulating TJs. Here, we have reviewed the recent findings on how Na,K-ATPase is involved in the regulation of TJs in vertebrates and non-vertebrates and suggest a conserved role for Na,K-ATPase in the regulation of TJ function.

3. TIGHT JUNCTIONS

Tight junctions (TJs) are the most apical components of the junctional complexes in epithelial cells that also include adherens junctions, desmosomes, and gap junctions. In transmission electron microsocopy, TJs appear as close contacts between adjacent cells, seemingly fusing the neighboring plasma membranes. At these sites of cell-cell contacts, the barrier is formed where strands of adhesive transmembrane proteins contact across the paracellular space, and it behaves as if perforated by pores possessing size and charge selectivity. The degree of sealing varies according to cell type, physiological stimuli, and pathological conditions and seems to be at least in part dependent on the pore number and the profile of claudins expressed (1). In addition to this gate function to regulate the passage of ions and small molecules, TJs also serve to maintain cell polarity by forming a fence within the plasma membrane that restricts the diffusion of proteins and lipids between the apical and basolateral surfaces. Recent evidence suggests that TJs have additional roles in cell signaling, regulating epithelial cell proliferation, differentiation, and gene expression (2, 3).

Tight junctions are multiprotein complexes composed of integral membrane proteins that mediate cell-cell adhesion and of cytoplasmic plaque proteins that serve as a bridge to the actin cytoskeleton, as a scaffold for the recruitment of signaling proteins, and as regulators of TJ assembly and function. A detailed description of the individual molecules and the regulation of TJ components by signaling pathways have been the focus of excellent recent reviews (2-5). In this review, we will highlight some of the main characteristics of TJs. Three families of transmembrane proteins of the TJs have been described, including claudins and occludin, which are both tetraspan proteins but do not share sequence homology, and the single transmembrane JAMs. Claudins (5, 6) are the major components forming the barrier of the TJ. They constitute a multigene family of at least 24 members in vertebrates ranging from 20 to 27 kDa (2, 5, 6) and have also been described in invertebrates such as zebrafish. Two claudin-like homologues in Drosophila SJs that are involved in forming the paracellular barrier have also been found (7, 8). Claudins mediate cell-cell adhesion independent of calcium and can associate homotypically or heterotypically with each other to form TJ strands in a tissue-specific manner (5). Together with the variability in the two extracellular loops that determine the paracellular barrier functions of the different claudin isoforms, this tissue-specific expression pattern is thought to be associated with the tissue-specific differences in TJ characteristics (5, 9-11). The C-terminal amino acids of claudins are highly conserved and, with the exception of claudin 12, end with PDZ-binding motifs, directly interacting with the PDZ domains of the zonula occludens scaffolding proteins ZO-1, ZO-2 and ZO-3 (12), as well as with multi-PDZ proteins (MUPP) (13, 14) and PATJ (15).

While it seems plausible that TJ functions are regulated through claudins, this is still an emerging field. Phosphorylation of claudins might be involved in regulating the paracellular barrier, and increased phosphorylation has been correlated with either decreased (e.g., claudin-3, 4) (16, 17) or increased (e.g., claudin-1) (18) barrier function. Treatment of intestinal epithelial cells with interferon (IFN)- induced the endocytosis of claudin-1 and increased the paracellular permeability (19). However, under these conditions, occludin is internalized as well (19, 20), making it difficult to confirm the specific role of claudins in the regulation of the paracellular permeability in this model. Regulation of claudin expression levels by growth factors has been reported frequently. In Madin-Darby canine kidney (MDCK) cells, epidermal growth factor receptor (EGFR) activation results in reduced claudin-2 and increased claudin-1, -3, and -4 expression, which is accompanied by an increase in transepithelial electrical resistance (TER) (21, 22). Hepatocyte growth factor (HGF) alters claudin expression and increases or decreases TER depending on the cell-type used in the study (23-26). Transforming growth factor (TGF)-3 downregulates the expression of claudin-11 in cultured Sertoli cells and inhibits the TJ permeability barrier (27). Expression of the transcription factor Snail during epithelial-to-mesenchymal transition (EMT) leads to downregulation of claudin and occludin expression and of the cell-cell adhesion molecule E-cadherin, and is associated with an increase in TJ permeability (28, 29). Apart from Snail, several transcription factors such as the -catenin/Tcf complex (30, 31) and the hepatocyte nuclear factor (HNF)-1 (32) were reported to regulate a variety of claudin promoters. Although much circumstantial evidence suggests that claudin integration into TJs is one mode of regulating the TJ barrier, the specific contributions and the physiologically relevant molecular mechanisms remain to be defined.

Occludin was the first transmembrane protein of the TJ to be identified and is one of the constituents of the TJ intermembrane strands (33). While over-expression of occludin increases TER in mammalian epithelial cells (34, 35), occludin per se is not required for the formation of TJ strands. Disruption of both occludin alleles in embryonic stem cells did not prevent their differentiation into polarized epithelial cells (36), and occludin null mice did not display obvious structural or functional TJ abnormalities (37). Although occludin does not seem to be essential for the TJ barrier function, recent evidence suggests a likely role in regulating various signaling events to and from TJs (2). Occludin is a ~60 kDa tetraspan membrane protein and has two extracellular loops and cytosolic amino- and carboxy-terminal domains. The carboxy-terminal domain associates with ZO-1, ZO-2 and ZO-3 and binds to the actin-myosin binding protein cingulin. It is rich in serine, threonine, and tyrosine residues, which are targets for several protein and tyrosine kinases such as the nonreceptor tyrosine kinase c-Yes (38), the serine/threonine kinases casein kinase (CK) 2 (39), and atypical protein kinase C (aPKC)- (38), as well as for the serine/threonine protein phosphatase 2A (PP2A) (40, 41). Occludin phosphorylation is further affected by a variety of signaling events that include growth factors such as vascular endothelial growth factor (VEGF) (42, 43) and TGF- (27) and signaling molecules involved in actin organization such as Rho/ROCK (44), including the activity of Na,K-ATPase (45). Occludin further interacts with the regulatory subunit p85 of the phosphatidyl-inositol 3 (PI3) kinase (38), actin (46), the E3 ubiquitin ligase Itch (47), and the gap junction protein connexin-32 (48). Transcriptional regulation of occludin by tumor necrosis factor (TNF)- (49) as well as Snail (29), which both also regulate claudin expression, has been reported. This array of mechanisms regulating occludin expression and function suggests that occludin could function to integrate a wide variety of signals and act as gate keeper to modulate TJ permeability.

The three members of the junctional adhesion molecule family, JAM-A, -B, and C have, unlike claudins and occludin, only a single transmembrane domain (50), and their extracellular domains contain two immunoglobulin-like motifs and dimerization motifs that play a role in their interactions (51, 52). The detailed role of JAMs in TJ function remains to be determined. Recent studies implicated JAM proteins in the epithelial barrier function, since inhibitory antibodies for JAM result in decreased TER and defects in TJ assembly (53). Like claudins and occludin, JAM proteins have a PDZ-binding motif at their C termini and interact with TJ scaffolding proteins that include ZO-1 (54). JAM-A interacts with MUPP-1 (13), afadin (54), the calcium/calmodulin-dependent serine protein kinase (CASK/Lin2) (55), MAGI-1 (56), PICK-1 (57) and Par-3 (58); these interactions appear to be important for proper TJ function (50).

The transmembrane TJ proteins, occludin, claudins, and JAMs, are linked to the actin cytoskeleton via the interaction of their intracellular domains with peripheral membrane proteins. Of these, the Zonula occludens proteins ZO-1 and its binding partners ZO-2 and ZO-3 are well-characterized (3, 59, 60). They are members of the membrane-associated guanylate kinase (MAGUK) family of proteins and are thought to regulate the kinetics of the assembly of TJs (61, 62). ZO-1, as with all MAGUK proteins, is characterized by its PDZ domain, SH3 domain, and the guanylate kinase homologous domain and, in addition, contains two nuclear localization signals and a carboxyl region with several proline-rich regions (60, 63). It has been proposed to be a scaffolding protein between transmembrane and cytoplasmic proteins of the TJs, as it can bind to occludin, claudins, and JAMs and F-actin, either directly or indirectly via actin-associated proteins such as cingulin and afadin (60, 63). In addition, ZO proteins interact with a multitude of other proteins. ZO-1 has been shown to bind to - and -catenin (64, 65), which are proteins associated with adherens junctions, and to transcription factors, such as ZONAB (ZO-1 associated nucleic acid binding) that regulates the promoter of erbB-2 (66). ZO-2 not only interacts with various nuclear proteins such as Jun, Fos, CCAAT/enhancer binding protein, and DNA-binding protein scaffold attachment factor B, but it also localizes to the nucleus, as does ZO-1, suggesting that they themselves could regulate transcription (67-71). As these are only a few of the factors that associate with ZO proteins, it is conceivable that the functions of these proteins and of TJs go well beyond a structural role. As more and more of these functions are being discovered, it is vital to determine the molecular factors that regulate TJs. While TJ function is affected by many growth factors, transcription factors, and other structural proteins, the regulation of TJs by ion channels and transporters is an emerging field and has been reviewed recently (72).

4. NA,K-ATPASE

4.1. Functions, subunits and isoforms

One of the better-known transporters that regulate TJ function is the Na,K-ATPase, a member of the family of cation transporting P-type ATPases. The Na,K-ATPase, also known as sodium pump, is found in the cells of all higher eukaryotes and transports 3 Na+ out and 2 K+ into the cell by hydrolyzing one molecule of ATP. In addition to maintaining the intracellular ion homeostasis, this pumping process generates a transmembrane electrochemical gradient that regulates other cellular activities such as secondary active transport of other ions, nutrients, and neurotransmitters, for maintaining intracellular pH, cell volume and size, and for electrical excitability. In most epithelial cells, the Na,K-ATPase is localized to the basolateral plasma membrane, and the gradients generated by Na,K-ATPase are involved in regulating directional transport of molecules across epithelial cells (73-75). Recent evidence suggests that Na,K-ATPase might have a more direct or indirect role in transport across the epithelial barrier by regulating TJ structure and permeability.

The functional Na,K-ATPase is a heterodimeric protein consisting of an -subunit and a -subunit (76, 77). A third tissue-specific regulatory -subunit, members of the FXYD family, has also been described (78-80). The -subunit is the catalytic subunit of the Na,K-ATPase, and four distinct isoforms have been identified in mammalian cells (1, 2, 3 and 4). Each has unique kinetic properties and a distinctive response to second messengers (81, 82). The -subunit has a molecular mass of about 110 kDa with 10 transmembrane segments with 5 extracellular loops and both termini located intracellularly. It contains the binding sites for Na+, K+, ATP and cardiotonic steroids such as the specific inhibitor ouabain (83). The recently published crystal structure of the Na-K-ATPase revealed that the carboxy terminus of the -subunit is contained within a pocket between the transmembrane helices as a regulatory element controlling sodium affinity and that the - and the -subunits are associated with the transmembrane helices M7 /M10 and M9, respectively (84).

The -subunit of Na,K-ATPase is a type II single membrane-spanning protein of about 370 amino acids, and three mammalian isoforms have been described (1, 2 and 3). The molecular mass of the -subunit is around 40-60 kDa and varies with tissue type and isoforms. There are 3 consensus N-glycosylation sequences in the extracellular domains of 1 and 3, and 7 in the 2-isoform (85-87). The precise role of the -subunit is still not known, and recent evidence suggests that it may have functions that are independent of its role in Na,K-ATPase enzyme activity. It is well-documented that the -subunit is essential for the appropriate folding of the -subunit in the endoplasmic reticulum and for the delivery of the -subunit to the plasma membrane (88), as well as for the retention of the enzyme in the plasma membrane, which is dependent on the glycosylation of the -subunit (89, 90). It has been suggested that the -subunit may be more intimately involved in regulating the active transport function of the -subunit as it is required for the occlusion of K+ ions (88, 91). The recent crystal structure studies revealed that the -subunit interacts with its Tyr 39, Phe42 and Tyr 43 with the -subunit, and its conserved glycines in the GXXXG motif are exposed on the other side (84). It has been suggested that this motif is important for the homodimerization of the -subunit and has a role in cell-cell adhesion (92, 93).

The -subunit of the Na,K-ATPase (now FXYD2) was originally identified as a component of Na,K-ATPase in sheep kidney (94), and subsequently, the third subunit of the Na,K-ATPase was identified in various other tissues including cancer tissues. These proteins belong to the family of FXYD proteins, and 7 members (FXYD1-7) have been reported to date. They are short polypeptides and are type I transmembrane proteins, except for FXYD3, which is a double-span protein. While it is now well accepted that FXYD proteins modify and fine-tune the transport properties of the Na,K-ATPase in a tissue- and isoform-specific manner (79, 80), it is not known whether FXYD proteins perform other cellular functions in addition to modulating the pump kinetics. For example, FXYD5 was originally identified as dysadherin and has been implicated in reduced E-cadherin expression, cancer progression, and metastasis (95, 96), but it remains to be determined whether this function is dependent or independent of its role in Na,K-ATPase enzymatic function.

4.2. Regulation and interaction with other proteins

Numerous mechanisms are involved in the regulation of the Na,K-ATPase to adapt to changing physiological demands. These include its own - and -subunits as well as intracellular Na+. Intracellular Na+ is the limiting factor for the pump function of the Na,K-ATPase, and any change in intracellular Na+ concentration affects its transport rate. A multitude of other factors such as endogenous cardiac glycosides (e.g., ouabain and its stereo or regioisomers and derivatives of bufadienolides) (97), corticosteroids (e.g., the mineralocorticoid aldosterone and the glucocorticoid dexamethasone), catecholamines (e.g., norepinephrine and dopamine), and peptide hormones (e.g., insulin, parathyroid hormone, angiotensin II) affect - and -subunit transcription as well as phosphorylation of the catalytic subunit (98). cAMP-dependent protein kinase A (PKA), cGMP-dependent protein kinases (PKG), Ca-phospholipid-dependent protein kinase (PKC), and atypical PKC-, tyrosine kinases and protein phosphatases have all been reported to regulate Na,K-ATPase through post-translational modification of the -subunit, ubiquitination, and endocytosis (98-100). Recently, phosphorylation of phospholemman (FXYD1) by PKA and PKC has been shown to regulate Na,K-ATPase in an isoform-dependent manner (101).

Na,K-ATPase subunits interact with a multitude of proteins including other ion transporters and structural and signaling proteins (72). The -subunit has been shown to interact with cytoskeletal proteins such as the actin binding protein ankyrin, which is important for the trafficking and targeting of the Na,K-ATPase (102, 103), and cofilin (104). Other proteins that have been shown to associate with Na,K-ATPase and modulate its trafficking are arrestin, spinophilin, G-protein-coupled receptor kinases, and 14-3-3  (105). The -subunit also interacts with proteins associated with the endocytic machinery such as the adapter protein AP-2, a clathrin adapter (106), and with caveolin (107), as well as with diverse other proteins such as polycystin-1 (108). Most importantly, recent evidence indicates that Na,K-ATPase associates with proteins involved in cell signaling, possibly forming a scaffolding platform (Figure 1). The -subunit binds several signaling molecules such as phosphoinositide-3 kinase (109), src (110), PP2A (45), phospholipase C (PLC)-1 (111), and inositol 1,4,5-trisphosphate (IP3) receptor (111). As new functions of the -subunit are being explored, new binding partners have also been identified, including the endoplasmic reticulum protein wolframin (112), annexin II (109), PP2A (45), retinoschisin (RS1) (113), and the small GTPases RalA and RalB (114).

4.3. Na,K-ATPase as a signaling molecule

The role of Na,K-ATPase as a modulator of cell signaling is becoming well accepted. Inhibition of Na,K-ATPase function by ouabain or by low K+ concentration increases the expression of the proto-oncogenes c-fos and c-jun (115) and the transcription factor AP-1 in conjunction with an increase in hypertrophic growth (116). Later studies showed that inhibition of Na,K-ATPase by ouabain leads to the activation of Ras and p42/44 mitogen-activated protein kinase (MAPK) (117). Xie's group reported that Na,K-ATPase binds src kinase to inhibit src function and that addition of ouabain frees the kinase domain to activate src in a pump-independent manner (110). They further suggested that this mechanism is involved in the transactivation of EGF receptor and the activation of the Grb2/Ras/Raf/MEK extracellular signal-regulated kinase cascade (110, 118-120). Ouabain-treatment as well as expression of Na,K-ATPase -subunit have been shown to activate PI3-kinase (109, 121, 122). Studies from our laboratory showed that inhibition of the Na,K-ATPase activity with its concomitant increase in intracellular sodium inhibits the activity of RhoA, a small GTPase involved in the regulation of actin polymerization in epithelial and other cell types (123). As it is well-known that the physical and functional coupling between Na,K-ATPase and the Na+/ Ca2+ exchanger regulates intracellular Ca2+ (124), this regulation also involves a more direct role of Na,K-ATPase via its interaction with PLC-1 and IP3 receptor, which can be phosphorylated in a ouabain- and src-dependent manner (110). Further effects of ouabain include the inhibition of PP2A activity (45), the activation of Ral-GTPase (114), and the generation of reactive oxygen species (ROS) (125, 126). Inhibition of the Na+/H+ exchanger NHE3 (127) by ouabain seems to be due to regulation of NHE3 trafficking relayed by ouabain-induced Na,K-ATPase signaling (128). While some of the signaling functions appear to be due to alterations of ionic homeostasis following inhibition of Na,K-ATPase (such as inactivation of RhoA), others have been shown to be independent of Na,K-ATPase pump function and are rather due to interaction of Na,K-ATPase subunits with signaling molecules (e.g., src and MAPK signaling). Deciphering the specific contributions of pump-dependent and independent signaling pathways to the Na,K-ATPase signaling function and the interplay between these pathways remains a challenge.

5. NA,K-ATPASE AND TIGHT JUNCTIONS

Studies from our laboratory provided experimental evidence that the enzymatic function and subunits of Na,K-ATPase themselves have a role in the organization and permeability of TJs. Expression of the 1-subunit of Na,K-ATPase in Moloney sarcoma virus (MSV) transformed MDCK cells that express E-cadherin, a calcium-dependent cell-cell adhesion molecule, induced functional TJs and epithelial polarity in this transformed cell line (129). MSV-MDCK cells express very low levels of E-cadherin (65, 129, 130). Exogenous expression of E-cadherin and Na,K-ATPase 1-subunit was sufficient to induce an epithelial phenotype with functional TJs. We, therefore, suggested that Na,K-ATPase 1-subunit functions synergistically with E-cadherin in the assembly and function of TJs. Interestingly, in these studies, expression of Na,K-ATPase 1-subunit together with E-cadherin reduced the higher intracellular Na+ level of MSV-MDCK cells to a more normal level as observed in MDCK cells. These low Na+ levels were not observed when Na,K-ATPase 1-subunit or E-cadherin was expressed alone, suggesting that low intracellular Na+ levels are required for epithelial polarization (129). In subsequent studies using the specific inhibitor ouabain and K+-depletion as independent methods to inhibit Na,K-ATPase activity, we further provided evidence for Na,K-ATPase enzyme activity in the regulation of TJs (45, 123, 131). Using MDCK cells in a calcium switch assay, we showed that inhibition of Na,K-ATPase activity prevented the formation of TJs. An increase in the intracellular Na+ by Na+ ionophores mimicked the effect of Na,K-ATPase inhibition on TJ formation, suggesting that epithelial cells require low intracellular Na+ to establish TJs and polarity. RhoA GTPase, which has been implicated in the regulation of TJs in epithelial cells (132-134), was considerably inhibited following inhibition of Na,K-ATPase function or Na+ ionophore treatment. Overexpression of wild-type RhoA GTPase significantly reduced the effect of Na,K-ATPase inhibition on TJ assembly, indicating that RhoA GTPase is a key molecule affected by Na,K-ATPase during epithelial polarization (123).

Based on our results, we proposed a two-step model for the assembly of TJs in epithelial cells. According to this model, the first step involves E-cadherin-mediated signaling events that translocate TJ proteins to the plasma membrane, where they assemble and form discontinuous TJ strands. The second step is regulated by Na,K-ATPase, which involves polymerization of actin mediated by RhoA GTPase that is involved in the mobility and cohesion of discontinuous TJ strands to form continuous strands necessary for the establishment of functional TJs (135). Although this model suggests that E-cadherin and Na,K-ATPase are two major players of TJ formation and a polarized phenotype in epithelial cells, it is likely that other signaling mechanisms modulated by these or other proteins are involved in the process of epithelial polarization.

Na,K-ATPase function is necessary not only for the formation of epithelial TJs but also to maintain TJ function and structure. In polarized primary cultures of human retinal pigment epithelium (RPE) cells and in a polarized pancreatic cell line, HPAF-II, inhibition of Na,K-ATPase function reduced TJ membrane contact points and increased permeability to both ionic and non-ionic molecules (45, 131). In HPAF-II cells, the Na,K-ATPase -subunit was associated with PP2A, a serine/threonine phosphatase localized to TJs. Inhibition of Na,K-ATPase activity considerably reduced PP2A activity, which correlated with increased phosphorylation of occludin and TJ permeability. Immunogold labeling and electron microscopy further confirmed that Na,K-ATPase -subunit is localized to the TJ and adherens junction region in addition to the basolateral plasma membrane (45). Co-immunoprecipitation analysis in HPAF-II cells suggests that occludin is associated with the Na,K-ATPase -subunit (Figure 2). These studies strongly suggest that Na,K-ATPase is also localized to the TJ and might be involved in the regulation of TJ structure, permeability, and signaling functions locally at the tight junction region. Whether Na,K-ATPase function regulates an ionic balance at the TJ region or modulates signaling via its interaction with other signaling molecules or the TJ proteins themselves requires future research.

6. NA,K-ATPASE IN THE DEVELOPMENT OF TIGHT JUNCTIONS

6.1. Na,K-ATPase in blastocyst development

During mammalian early development, the first epithelial structure that emerges is the trophectoderm epithelium covering the surface of the blastocyst and enclosing the inner cell mass (136, 137). The mouse trophectoderm emerges at the morula stage of an 8-cell embryo, as compaction becomes the first morphogenetic event of preimplantation development. This stage is characterized by increased cell-to-cell contact and the gradual assembly of adherens junctions followed by desmosomes, TJs, and cell polarization (138). As the outer blastomeres proceed to acquire complete epithelial characteristics to form the trophectoderm at the 32-cell stage, blastocyst formation (cavitation) is initiated following the establishment of ion gradients and osmotic fluid accumulation across the trophectoderm epithelium (139). The paracellular seal formed by TJs between adjacent trophectoderm is essential for the transepithelial transport processes, and the barrier function of the TJs in the trophectoderm is required for normal blastocyst formation (140).

It has been well documented that the Na,K-ATPase and the sodium gradient generated by its pump function provides the driving force for the vectorial transepithelial transport processes and promotes the osmotic accumulation of water across the epithelium (139, 141). Nevertheless, deletion of the Na,K-ATPase -subunit gene (Atp11) did not prevent cavitation of the preimplantation mouse embryo but subsequently failed during the peri-implantation phase of development (142). Mouse embryos homozygous for a null mutation in the 1-subunit gene were able to undergo compaction and cavitation, suggesting that other -subunit isoforms are present that allow for the blastocyst formation to progress in the absence of the 1 isoform. However, in subsequent studies by Violette et al (143) inhibition of the Na,K-ATPase enzymatic function allowed the mouse embryos to develop normally to the blastocyst stage (up to 6 hours) but affected the distribution of TJ proteins such as ZO-1 and occludin. The TJ barrier function was affected as demonstrated by their increased permeability to 4 kDA and 40 kDa FITC-dextran, suggesting that Na,K-ATPase is a key regulator of trophectoderm TJ function during murine preimplantation development. These studies were further confirmed as mouse embryos injected with Na,K-ATPase 1-subunit siRNA oligos failed to develop to the blastocyst stage (144). In addition, studies by Eckert et al (145) showed recently that inhibition of PKC delayed cavitation. Inhibition of cavitation with the a PKC inhibiting peptide was found to coincide with rapid internalization of the -subunit of the Na,K-ATPase. These studies collectively demonstrated that Na,K-ATPase enzyme activity as well as its subunits play a role in blastocyst formation through the regulation of TJ formation and function during preimplantation development in mouse embryos as we have demonstrated using cultured cell lines (45, 123, 129, 131, 135).

6.2 Na,K-ATPase in zebrafish

In zebrafish, 9 -subunits and 6 -subunit genes have been identified (146-149). The zebrafish 1B1 subunit of Na,K-ATPase is encoded by the heart and mind (had) locus. In the developing heart, as the primitive heart tube grows, complex morphogenic events transforming sheets of cardiac precursors into a three-dimensional structure take place (150-152). Shu et al (153) identified a zebrafish mutant, heart and mind (had), which caused severe abnormalities in primitive heart tube extension, cardiomyocyte differentiation, and embryonic cardiac function in an isoform-dependent manner, indicating a crucial role for the Na,K-ATPase 1B1 in zebrafish heart development. Inhibition of Na,K-ATPase 1B1 activity with ouabain produced the had mutant phenotype, and over-expression of 1B1 rescued the had cardiac phenotype, further supporting the hypothesis that mutations in 1B1 are responsible for the had phenotype. This group further suggested that Na,K-ATPase might regulate heart tube extension by rearranging the actin cytoskeleton and by regulating the polarity of cardiac cells as we have shown in cultured cells (123, 131).

In addition, recent studies in zebrafish suggest a role for Na,K-ATPase in myocardial cell junction maintenance (154). Mutations of 1B1 cause heart tube elongation defects and other developmental abnormalities that are reminiscent of several epithelial cell polarity mutants (152, 155-157), suggesting a common defect underlying the loss of myocardial morphogenetic potential. Indeed, Cibrian-Uhalte et al. (154) demonstrated in zebrafish genetic interactions between Had and Nok, a TJ-associated scaffolding protein of the apical crumbs polarity complex involved in the maintenance of ZO-1-positive junction belts within myocardial cells, and that maintenance of ZO-1 junction belts required the Na,K-ATPase pump activity. As suggested by the authors, the correct ionic gradients modulated by Had may stabilize the integrity of the TJ and the paracellular diffusion barrier, which is consistent with our finding in polarized epithelial cells. Further, recent studies also suggest a role for Na,K-ATPase in otolith formation and semicircular canal development (147) as well as in single lumen development in the zebrafish gut (158). It remains to be determined whether the electrochemical gradient generated by the Na,K-ATPase or Na,K-ATPase subunits' interaction with other regulatory proteins are involved in the lumen development in the zebrafish gut.

6.3. Drosophila and septate junctions

The SJs in invertebrates are the functional equivalent of TJs in vertebrates (6) as they both are part of the paracellular transport pathway in epithelial tissues. Although TJs and SJs share the characteristic of being a permeability barrier, they are also distinct in various ways. While TJs appear as sites where the extracellular leaflets of the plasma membrane seem to fuse, SJs are characterized by a constant intercellular cleft of ~ 15-20 nm between adjacent cells. These clefts are either continuous or bridged with spaced bridges called septa (159). TJs are located at the most-apical pole of the lateral plasma membrane above the adherens junctions whereas SJs are found more basal below the adherens junction (160). Further, the vertebrate homologues of most SJ-associated proteins are not found in TJs, except for claudins (7, 8). Interestingly, we found that Na,K-ATPase 1-subunit is localized to TJs and that the -subunit associates with occludin in HPAF-II cells (Figure 2). In Drosophila, both subunits of Na,K-ATPase, - (ATPa ) and b - (Nrv2) are concentrated at the SJs (161-163). The significance of this is not known at this time but points to a conserved role for Na,K-ATPase in TJ/SJ function.

In Drosophila, there are two -subunit loci, ATP that produces at least 12 -subunit isoforms and three -subunit loci, nrv1 and nrv3, which produce one isoform each, and nrv2, which encodes two isoforms, Nrv2.1 and Nrv2.2 (164). Data from immunoprecipitations and somatic mosaic studies suggest that ATP and Nrv2 form an interdependent protein complex with Coracle (COR), Neurexin (NRX), Gliotactin and Neuroglian (NRG); some of which were previously known to localize to SJs (161). Mutations of both ATP and Nrv2 were associated with a structural loss of the SJs accompanied by the disruption of the paracellular barrier function in the salivary gland. Analysis of the ultra structure of the SJs by transmission electron microscopy revealed that while the adherens junctions remained intact, the septae were disrupted, suggesting that Na,K-ATPase is necessary for establishing and maintaining SJs, the primary paracellular barrier in invertebrate epithelia (161). Besides the salivary gland, ATP and Nrv2 but not other Drosophila Na,K-ATPase -subunits were also found to be essential for the SJ function and epithelial tube size control in the Drosophila tracheal system and in epidermis (163). In a later study, the junctional activity of the Na,K-ATPase was found to be mediated by specific isoforms of the ATP and by the extracellular domain of Nrv2. However, mutations predicted to block ion-pump activity had no effect on SJ formation, suggesting that the formation of SJs and the diameter of the tubes are independent of the pump function of the Na,K-ATPase (162).

The studies by both groups (161-163) pointed to a specific role for Na,K-ATPase in SJ function, as mutations of the Na,K-ATPase subunits did not cause the loss of adherens junctions. Immunofluorescence studies of the adherens junction components E-cadherin (Shotgun) and -catenin (Armadillo) showed that the localization and levels were unaffected (162, 163), but ultrastructural studies revealed the presence of SJs (161). Interestingly, we found that in the mammalian MSV-MDCK cells, expression of E-cadherin restored the assembly of adherens junctions but TJs were not induced. Nevertheless, expression of Na,K-ATPase 1-subunit in these cells induced the formation of TJs (129). Similarly, inhibition of the Na,K-ATPase activity prevented the assembly of TJs but not adherens junctions (123). This suggests a specific role for Na,K-ATPase in the formation and regulation of the paracellular TJ barrier in both vertebrate cells and Drosophila.

7. FUTURE PERSPECTIVES

7.1. Na,K-ATPase, a member of the tight junction protein complex

The recent flurry of papers on the role of Na,K-ATPase in vertebrate TJ and Drosophila SJ structure and functions points to a conserved role of Na,K-ATPase in regulating the paracellular barrier in vertebrates and insects. The molecular aspects of this discovery are still in their infancy, and the next step will be to uncover the signals that are transmitted from the Na,K-ATPase to regulate the structure and function of these junctions. It is likely that the enzyme activity of the Na,K-ATPase and the intracellular ion homeostasis associated with it, as well as the - and the -subunits themselves independent of the ion transport function, regulate TJ function. As Na,K-ATPase has been found to be localized to TJs in vertebrates and SJs in insects, it is possible that the subunits directly or indirectly associate with TJ proteins to regulate structure and function. Density gradient centrifugation analysis of the epithelial apical junctional complex revealed that Na,K-ATPase co-distributed with the E-cadherin, -catenin/-catenin complex as well as with occludin and to some extent with ZO-1 and ZO-2 (165). We found that in HPAF-II cells, the Na,K-ATPase -subunit and occludin were associated with each other as determined by co-immunoprecipitation and GST-pull down assays (Figure 2). Other proteins that are localized to the TJ complex or interact with TJ-associated proteins have as well been found to associate with Na,K-ATPase including annexin II (109, 166), IP3 receptor (111, 167), PP2A (40, 45), p85 subunit of PI3 kinase (38, 109), and Ral A (114, 168). It is also well known that Na,K-ATPase binds the actin-binding proteins ankyrin and spectrin (102, 103). In the case of the adherens junction protein E-cadherin, we found that expression of the Na,K-ATPase -subunit in MSV-MDCK cells reduced the solubility of E-cadherin in Triton-X-100 extractions (129), and Vagin et al. (169) recently showed that the solubility of E-cadherin is increased when the glycosylation of the -subunit is prevented. Together, these studies suggest that Na,K-ATPase strengthens E-cadherin's association with the actin cytoskeleton probably by recruiting more actin to the subplasma membrane region. Similarly, it is possible that Na,K-ATPase localized to the TJ region might recruit actin and actin-crosslinking proteins to further strengthen the association of TJ proteins with the actin cytoskeleton, which is involved in the regulation of the TJ permeability.

7.2. Na,K-ATPase -subunit, a cell adhesion molecule

The integral membrane proteins of the TJs, claudins, occludin and JAMs have been found to have cell adhesion function through homotypic or heterotypic interactions. The Ca2+-independent adhesion molecule on glia (AMOG) was originally identified as a molecule involved in cell adhesion as monoclonal AMOG antibody blocked neuron-glia adhesion (170). Gloor et al. (85) reported later that AMOG actually was the 2-isoform of the Na,K-ATPase. More recently, the 1-isoform has also gained attention as a molecule involved in cell-cell adhesion. In our initial studies, we showed that expression of the 1-subunit in MSV-MDCK cells increased the cell-cell adhesion in a cell aggregation assay and suggested that the 1-subunit might have a potential cell-cell adhesion function (129). Similarly, expression of the 1-subunit in Chinese hamster ovary (CHO) fibroblast cells conferred adhesive properties when these cells were co-cultured with MDCK cells (89). Recent studies suggest that the transmembrane domain as well as glycosylation of the 1-subunit confer adhesive properties. Work from our group provided a model in which the glycine zipper motif in the 1-subunit transmembrane mediates 1-1 oligomerization. Mutations in the GxxxG motif abolished the cell-cell aggregation in MSV-MDCK cells compared to cells overexpressing the wildtype 1-subunit (92). The extracellular domain of the 1-subunit contains three N-glycosylation consensus sites with all three being heavily glycosylated. Initial studies on the glycosylation pattern revealed that the predominant glycans of the 1-subunit were a combination of the tetraantennary glycan form and the unusual glycan form of the tetraantennary with a limited number of repeating N-acetyl-lactosamine units (171). The glycan structures found in the 1-subunit are processed to the same extent as adhesion molecules, and the authors concluded that the 1-subunit may be related to an adhesion molecule. More recent studies found that the N-glycans of the 1-subunit are indeed important for its cell adhesion activity (90, 169, 172, 173). Although these recent studies provided a basis for the 1-subunit as a cell adhesion molecule, whether the cell-cell adhesion function is independent of the pump function of the Na,K-ATPase is still not conclusively demonstrated. However, we showed that the homodimerization of the -subunit and its role in cell-cell adhesion could occur when the -/-subunit interaction was diminished by specific mutation of amino acid residues in the transmembrane domain of the -subunit (92). It is not known whether a separate pool of -subunit not associated with the -subunit does exist and whether this pool would be involved in cell-cell adhesion, and this is a subject for future research. Towards this line, in a recent study, Xie and his coworkers identified a pool of non-pumping Na,K-ATPase (174), which might prove useful to address some of these questions in the future.

7.3. Na,K-ATPase, a signaling scaffold that regulates tight junctions

Experimental evidence suggests that the Na,K-ATPase could act as a signaling scaffold that might either be associated with the TJ complex or in the vicinity of the TJs. Treatment of cells with the glycoside ouabain is involved in the activation of several signaling pathways; some of which seem to be activated independent of the pump function of the Na,K-ATPase (109, 120, 135, 175). Interestingly, some of the Na,K-ATPase-mediated signaling events seem to overlap with signaling pathways that have been shown to regulate TJs. For example, inhibition of Na,K-ATPase by ouabain or K+ depletion leads to the inhibition of RhoA, an effect mimicked by the sodium ionophore gramicidin (123). The activity of the small GTPase RhoA is required for the formation of actin stress fibers (176) and regulates the barrier function of TJs (132-134). Na,K-ATPase can also form a signaling complex with src with ouabain treatment inducing the activation of Src and Erk1/2 independent of the pump function (110). The heterotrimeric G-protein G12 has been shown to regulate MDCK TJs at least in part through the Src kinase signaling pathway (177, 178), and in Caco-2 cells, oxidative stress-induced disruption of TJs is mediated by the activation of c-Src (179). In ras-transformed MDCK cells, down-regulation of the MAPK pathway restored the TJ structure and barrier function (180). Likewise, activation of the Erk1/2 MAP kinase pathway induces TJ disruption in human corneal epithelial cells (181). In contrast to these studies, MAPK has also been suggested to mediate EGF-induced prevention of TJ disruption through its interaction with occludin (182). The polarity complex protein Par-3 regulates TJ assembly through EGFR signaling (183). Ouabain-treatment of LLC-PK1 has been suggested to transactivate EGFR in a pump-independent manner (118, 119). However, palytoxin down-modulates the epidermal growth factor receptor (EGFR) through a sodium-dependent pathway in Swiss 3T3 cells (184, 185). Palytoxin binds to the Na,K-ATPase, basically converting it to an open channel resulting in increased intracellular sodium (186, 187). As EGFR is a common element in the signaling pathways activated by cell volume changes in isosmotic, hyposmotic, or hyperosmotic conditions (188), it remains to be determined how tight junction regulation through EGFR activation by Na,K-ATPase is connected. Na,K-ATPase also plays a role in IP3 receptor, PI3 kinase, and PLC-1 signaling, all pathways that also have been implicated in the regulation of TJ function (2-5, 189). PP2A associates with both Na,K-ATPase and occludin and studies from our laboratory showed that inhibition of Na,K-ATPase enzyme activity inhibits PP2A activity, leading to the hyperphosphorylation of occludin and decrease in the TJ barrier in HPAF-II cells (45). The relative contributions of pump-dependent and -independent signaling by Na,K-ATPase in regulating tight junction permeability remain to be determined (190).

Many pathways that regulate TJ function also regulate Na,K-ATPase, such as IFN- (191), growth factors, PKC, and many more (98, 153). One of the best-known transcriptional regulators associated with the loss of TJ function in cancer cells is Snail. This transcription suppressor is induced in cells undergoing EMT and reduces the transcription of genes associated with junctional complexes in epithelial cells (28, 29, 192-194). Interestingly, Na,K-ATPase 1-subunit is transcriptionally suppressed by Snail, whereas the -subunit is not affected (195). It is possible that Snail targets a set of proteins associated with junctional complexes to accomplish EMT in cancer cells.

8. SODIUM/ION HOMEOSTASIS AND TIGHT JUNCTIONS

Recently, several ion transporters and channels have been identified as having a function to modulate TJ structure and paracellular permeability (72). As the function of Na,K-ATPase is crucial to maintaining the intracellular ion homeostasis, it is possible that some of the effects of other channels/transporters on TJ function are connected to the function of Na,K-ATPase in the paracellular barrier. For example, apical glucose uptake through the Na+-glucose transporter SGLT-1 induces a drop in TER (196) and increases paracellular permeability in cultured Caco-2 cells as well as in vivo in rats and in healthy human subjects (197, 198). Also, the intestinal Na+/H+ exchanger NHE3 has been shown to regulate TER (199). We can envision that the signaling scaffolding complex of the Na,K-ATPase might sense changes in the intracellular ionic milieu, as the transport processes of SGLT-1 and NHE3 are probably associated with an increase in the intracellular Na+ concentration. These changes in Na+ concentration might then target the phosphorylation status of TJ proteins through signaling events involving the Na,K-ATPase leading to alterations in TJ structure and function. Recently, it has been shown that ouabain treatment of LLC-PK1 cells downregulated NHE3 activity and expression. Liu's group reported that activation of the Na,K-ATPase receptor complex by ouabain at concentrations that do not increase intracellular Na+ regulates the trafficking of NHE3 (127, 128). It is possible that Na,K-ATPase might act to integrate changes in intracellular ionic milieu as well as signals obtained from the extracellular environment to regulate TJ permeability.

9. A ROLE FOR Na,K-ATPASE IN EPITHELIAL-MESENCHYMAL TRANSITION (EMT) AND CANCER

TJs are crucial for the normal structure and functioning of epithelial cells. In cancer, in the course of malignant cell transformation, TJs are generally lost (200). Coincidentally, changes in Na,K-ATPase function have been reported either as an increase in activity (201-203) or as inhibition (204). There is evidence that changes in Na,K-ATPase activity are already present at very early stage of tumorigenesis, even before gross tumors develop (204, 205). Changes in Na,K-ATPase subunit levels have also been reported in poorly differentiated cell lines (129, 195) and in tumors/tumor cell lines including kidney (206, 207), colon (208), prostate (209, 210), pancreas (211), and lung (212); in hepatic (211), breast (211), and bladder cancer (213), as well as neuroblastoma (211) and metastatic melanoma (214). In bladder and kidney cancer, the - and -subunit expressions predict recurrence and survival, respectively (207, 213). Other studies emphasized the presence of specific cancer-related FXYD proteins such as FXYD3 (Mat-8, a mammary tumor marker) in breast and prostate cancer and FXYD5 that is expressed in cancer tissues but only a few normal cell types (80, 215). Together, these studies suggest that alterations in Na,K-ATPase function and expression might be associated with the loss of TJs in the process of tumorigenesis.

10. CONCLUSIONS

With our present understanding of Na,K-ATPase's role in TJ structure and function, it is quite possible that altered Na,K-ATPase function/expression might be a contributing factor in the development of cancer and other diseases associated with TJ malfunction. For example, mutations in the -subunit of Na,K-ATPase in kidney, FXYD2, have been linked to dominant renal hypomagnesemia (216). Interestingly, mutations in claudin16 (paracellin-1) were found in autosomal recessive hypomagnesemia (217). Whether FXYD2 and claudin-16 are functionally linked remains to be determined. Studies in inflammatory bowel disease, Crohn's disease, and ulcerative colitis indicated a decrease in Na,K-ATPase activity (218-220). Recent studies suggest a more direct role for Na,K-ATPase in these diseases, as pro-inflammatory cytokines inhibit Na,K-ATPase to downregulate the intestinal barrier function (191, 221). These studies suggest that Na,K-ATPase is a multifunctional protein, and changes in its function might be associated with many human diseases. Deciphering how Na,K-ATPase function is altered might provide insight into disease mechanisms as well as novel therapeutic approaches.

10. ACKNOWLEDGEMENTS

This work was supported by DK56216 to A.K.R and funds from the Nemours Foundation to A.K.R. and S.A.R. We thank Dr. Sonali Barwe for her technical support.

11. REFERENCES

1. Van Itallie C. M., J. Holmes, A. Bridges, J. L. Gookin, M. R. Coccaro, W. Proctor, O. R. Colegio and J. M. Anderson: The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci, 121, 298-305 (2008)
doi:10.1242/jcs.021485

2. Schneeberger E. E. and R. D. Lynch: The tight junction: a multifunctional complex. Am J Physiol Cell Physiol, 286, C1213-1228 (2004)
doi:10.1152/ajpcell.00558.2003

3. Shin K., V. C. Fogg and B. Margolis: Tight junctions and cell polarity. Annu Rev Cell Dev Biol, 22, 207-235 (2006)
doi:10.1146/annurev.cellbio.22.010305.104219

4. Gonzalez-Mariscal L., R. Tapia and D. Chamorro: Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta, 1778, 729-756 (2008)
doi:10.1016/j.bbamem.2007.08.018

5. Van Itallie C. M. and J. M. Anderson: Claudins and epithelial paracellular transport. Annul Rev Physiol, 68, 403-429 (2006)
doi:10.1146/annurev.physiol.68.040104.131404

6. Furuse M. and S. Tsukita: Claudins in occluding junctions of humans and flies. Trends Cell Biol, 16, 181-188 (2006)
doi:10.1016/j.tcb.2006.02.006

7. Behr M., D. Riedel and R. Schuh: The claudin-like megatrachea is essential in septate junctions for the epithelial barrier function in Drosophila. Dev Cell, 5, 611-620 (2003)
doi:10.1016/S1534-5807(03)00275-2

8. Wu V. M., J. Schulte, A. Hirschi, U. Tepass and G. J. Beitel: Sinuous is a Drosophila claudin required for septate junction organization and epithelial tube size control. J Cell Biol, 164, 313-323 (2004)
doi:10.1083/jcb.200309134

9. Amasheh S., N. Meiri, A. H. Gitter, T. Schoneberg, J. Mankertz, J. D. Schulzke and M. Fromm: Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci, 115, 4969-4976 (2002)
doi:10.1242/jcs.00165

10. Colegio O. R., C. Van Itallie, C. Rahner and J. M. Anderson: Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol, 284, C1346-1354 (2003)

11. Van Itallie C. M., A. S. Fanning and J. M. Anderson: Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol, 285, F1078-1084 (2003)

12. Itoh M., M. Furuse, K. Morita, K. Kubota, M. Saitou and S. Tsukita: Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol, 147, 1351-1363 (1999)
doi:10.1083/jcb.147.6.1351

13. Hamazaki Y., M. Itoh, H. Sasaki, M. Furuse and S. Tsukita: Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem, 277, 455-461 (2002)
doi:10.1074/jbc.M109005200

14. Jeansonne B., Q. Lu, D. A. Goodenough and Y. H. Chen: Claudin-8 interacts with multi-PDZ domain protein 1 (MUPP1) and reduces paracellular conductance in epithelial cells. Cell Mol Biol, 49, 13-21 (2003)

15. Roh M. H., C. J. Liu, S. Laurinec and B. Margolis: The carboxyl terminus of zona occludens-3 binds and recruits a mammalian homologue of discs lost to tight junctions. J Biol Chem, 277, 27501-27509 (2002)
doi:10.1074/jbc.M201177200

16. D'Souza T., R. Agarwal and P. J. Morin: Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J. Biol. Chem., 280, 26233-26240 (2005)
doi:10.1074/jbc.M502003200

17. D'Souza T., F. E. Indig and P. J. Morin: Phosphorylation of claudin-4 by PKC (epsilon) regulates tight junction barrier function in ovarian cancer cells. Exp Cell Res, 313, 3364-3375 (2007)
doi:10.1016/j.yexcr.2007.06.026

18. Fujibe M., H. Chiba, T. Kojima, T. Soma, T. Wada, T. Yamashita and N. Sawada: Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. Exp Cell Res, 295, 36-47 (2004)
doi:10.1016/j.yexcr.2003.12.014

19. Bruewer M., M. Utech, A. I. Ivanov, A. M. Hopkins, C. A. Parkos and A. Nusrat: Interferon-{gamma} induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J., 19, 923-933 (2005)
doi:10.1096/fj.04-3260com

20. Utech M., A. I. Ivanov, S. N. Samarin, M. Bruewer, J. R. Turner, R. J. Mrsny, C. A. Parkos and A. Nusrat: Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell, 16, 5040-5052 (2005)
doi:10.1091/mbc.E05-03-0193

21. Singh A. B. and R. C. Harris: Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J Biol Chem, 279, 3543-3552 (2004)
doi:10.1074/jbc.M308682200

22. Singh A. B., K. Sugimoto, P. Dhawan and R. C. Harris: Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance. Am J Physiol Cell Physiol, 293, C1660-1668 (2007)
doi:10.1152/ajpcell.00274.2007

23. Khoury H., M. A. Naujokas, D. Zuo, V. Sangwan, M. M. Frigault, S. Petkiewicz, D. L. Dankort, W. J. Muller and M. Park: HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion. Mol. Biol. Cell, 16, 550-561 (2005)
doi:10.1091/mbc.E04-07-0567

24. Lipschutz J. H., S. Li, A. Arisco and D. F. Balkovetz: Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J. Biol. Chem., 280, 3780-3788 (2005)
doi:10.1074/jbc.M408122200

25. Martin T. A., G. Watkins, R. E. Mansel and W. G. Jiang: Hepatocyte growth factor disrupts tight junctions in human breast cancer cells. Cell Biol Int, 28, 361-371 (2004)
doi:10.1016/j.cellbi.2004.03.003

26. Pollack A. L., G. Apodaca and K. E. Mostov: Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity. Am J Physiol Cell Physiol, 286, C482-494 (2004)
doi:10.1152/ajpcell.00377.2003

27. Lui W. Y., W. M. Lee and C. Y. Cheng: Transforming growth factor-beta3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11. Endocrinology, 142, 1865-1877 (2001)
doi:10.1210/en.142.5.1865

28. Carrozzino F., P. Soulie, D. Huber, N. Mensi, L. Orci, A. Cano, E. Feraille and R. Montesano: Inducible expression of Snail selectively increases paracellular ion permeability and differentially modulates tight junction proteins. Am J Physiol Cell Physiol, 289, C1002-1014 (2005)
doi:10.1152/ajpcell.00175.2005

29. Ikenouchi J., M. Matsuda, M. Furuse and S. Tsukita: Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci, 116, 1959-1967 (2003)
doi:10.1242/jcs.00389

30. Mankertz J., B. Hillenbrand, S. Tavalali, O. Huber, M. Fromm and J. D. Schulzke: Functional crosstalk between Wnt signaling and Cdx-related transcriptional activation in the regulation of the claudin-2 promoter activity. Biochem Biophys Res Commun, 314, 1001-1007 (2004)
doi:10.1016/j.bbrc.2003.12.185

31. Miwa N., M. Furuse, S. Tsukita, N. Niikawa, Y. Nakamura and Y. Furukawa: Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res, 12, 469-476 (2001)

32. Sakaguchi T., X. Gu, H. M. Golden, E. Suh, D. B. Rhoads and H. C. Reinecker: Cloning of the human claudin-2 5'-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J Biol Chem, 277, 21361-21370 (2002)
doi:10.1074/jbc.M110261200

33. Furuse M., T. Hirase, M. Itoh, A. Nagafuchi, S. Yonemura and S. Tsukita: Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol, 123, 1777-1788 (1993)
doi:10.1083/jcb.123.6.1777

34. Balda M. S., J. A. Whitney, C. Flores, S. Gonzalez, M. Cereijido and K. Matter: Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol, 134, 1031-1049 (1996)
doi:10.1083/jcb.134.4.1031

35. McCarthy K. M., I. B. Skare, M. C. Stankewich, M. Furuse, S. Tsukita, R. A. Rogers, R. D. Lynch and E. E. Schneeberger: Occludin is a functional component of the tight junction. J Cell Sci, 109, 2287-2298 (1996)

36. Saitou M., K. Fujimoto, Y. Doi, M. Itoh, T. Fujimoto, M. Furuse, H. Takano, T. Noda and S. Tsukita: Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol, 141, 397-408 (1998)
doi:10.1083/jcb.141.2.397

37. Saitou M., M. Furuse, H. Sasaki, J. D. Schulzke, M. Fromm, H. Takano, T. Noda and S. Tsukita: Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell, 11, 4131-4142 (2000)

38. Nusrat A., J. A. Chen, C. S. Foley, T. W. Liang, J. Tom, M. Cromwell, C. Quan and R. J. Mrsny: The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction. J Biol Chem, 275, 29816-29822 (2000)
doi:10.1074/jbc.M002450200

39. Smales C., M. Ellis, R. Baumber, N. Hussain, H. Desmond and J. M. Staddon: Occludin phosphorylation: identification of an occludin kinase in brain and cell extracts as CK2. FEBS Lett, 545, 161-166 (2003)
doi:10.1016/S0014-5793(03)00525-8

40. Nunbhakdi-Craig V., T. Machleidt, E. Ogris, D. Bellotto, C. L. White, 3rd and E. Sontag: Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol, 158, 967-978 (2002)
doi:10.1083/jcb.200206114

41. Seth A., P. Sheth, B. C. Elias and R. Rao: Protein phosphatases 2A and 1 interact with occludin and negatively regulate the assembly of tight junctions in the CACO-2 cell monolayer. J Biol Chem, 282, 11487-11498 (2007)
doi:10.1074/jbc.M610597200

42. Antonetti D. A., A. J. Barber, L. A. Hollinger, E. B. Wolpert and T. W. Gardner: Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem, 274, 23463-23467 (1999)
doi:10.1074/jbc.274.33.23463

43. Harhaj N. S., E. A. Felinski, E. B. Wolpert, J. M. Sundstrom, T. W. Gardner and D. A. Antonetti: VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci, 47, 5106-5115 (2006)
doi:10.1167/iovs.06-0322

44. Hirase T., S. Kawashima, E. Y. M. Wong, T. Ueyama, Y. Rikitake, S. Tsukita, M. Yokoyama and J. M. Staddon: Regulation of tight junction permeability and occludin phosphorylation by RhoA-p160ROCK-dependent and -independent mechanisms. J. Biol. Chem., 276, 10423-10431 (2001)
doi:10.1074/jbc.M007136200

45. Rajasekaran S. A., S. P. Barwe, J. Gopal, S. Ryazantsev, E. E. Schneeberger and A. K. Rajasekaran: Na-K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells. Am J Physiol Gastrointest Liver Physiol, 292, G124-133 (2007)
doi:10.1152/ajpgi.00297.2006

46. Wittchen E. S., J. Haskins and B. R. Stevenson: Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem, 274, 35179-35185 (1999)
doi:10.1074/jbc.274.49.35179

47. Traweger A., D. Fang, Y. C. Liu, W. Stelzhammer, I. A. Krizbai, F. Fresser, H. C. Bauer and H. Bauer: The tight junction-specific protein occludin is a functional target of the E3 ubiquitin-protein ligase itch. J Biol Chem, 277, 10201-10208 (2002)
doi:10.1074/jbc.M111384200

48. Kojima T., Y. Kokai, H. Chiba, M. Yamamoto, Y. Mochizuki and N. Sawada: Cx32 but not Cx26 is associated with tight junctions in primary cultures of rat hepatocytes. Exp Cell Res, 263, 193-201 (2001)
doi:10.1006/excr.2000.5103

49. Mankertz J., S. Tavalali, H. Schmitz, A. Mankertz, E. O. Riecken, M. Fromm and J. D. Schulzke: Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J Cell Sci, 113, 2085-2090 (2000)

50. Mandell K. J. and C. A. Parkos: The JAM family of proteins. Adv Drug Deliv Rev, 57, 857-867 (2005)
doi:10.1016/j.addr.2005.01.005

51. Kostrewa D., M. Brockhaus, A. D'Arcy, G. E. Dale, P. Nelboeck, G. Schmid, F. Mueller, G. Bazzoni, E. Dejana, T. Bartfai, F. K. Winkler and M. Hennig: X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J, 20, 4391-4398 (2001)
doi:10.1093/emboj/20.16.4391

52. Mandell K. J., B. A. Babbin, A. Nusrat and C. A. Parkos: Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity. J Biol Chem, 280, 11665-11674 (2005)
doi:10.1074/jbc.M412650200

53. Liu Y., A. Nusrat, F. J. Schnell, T. A. Reaves, S. Walsh, M. Pochet and C. A. Parkos: Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci, 113, 2363-2374 (2000)

54. Ebnet K., C. U. Schulz, M. K. Meyer Zu Brickwedde, G. G. Pendl and D. Vestweber: Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem, 275, 27979-27988 (2000)

55. Martinez-Estrada O. M., A. Villa, F. Breviario, F. Orsenigo, E. Dejana and G. Bazzoni: Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells. J Biol Chem, 276, 9291-9296 (2001)
doi:10.1074/jbc.M006991200

56. Hirabayashi S., M. Tajima, I. Yao, W. Nishimura, H. Mori and Y. Hata: JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. Mol Cell Biol, 23, 4267-4282 (2003)
doi:10.1128/MCB.23.12.4267-4282.2003

57. Reymond N., S. Garrido-Urbani, J. P. Borg, P. Dubreuil and M. Lopez: PICK-1: a scaffold protein that interacts with Nectins and JAMs at cell junctions. FEBS Lett, 579, 2243-2249 (2005)
doi:10.1016/j.febslet.2005.03.010

58. Ebnet K., A. Suzuki, Y. Horikoshi, T. Hirose, M. K. Meyer Zu Brickwedde, S. Ohno and D. Vestweber: The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J, 20, 3738-3748 (2001)
doi:10.1093/emboj/20.14.3738

59. Gonzalez-Mariscal L., A. Betanzos and A. Avila-Flores: MAGUK proteins: structure and role in the tight junction. Semin Cell Dev Biol, 11, 315-324 (2000)
doi:10.1006/scdb.2000.0178

60. Gonzalez-Mariscal L., A. Betanzos, P. Nava and B. E. Jaramillo: Tight junction proteins. Prog Biophys Mol Biol, 81, 1-44 (2003)
doi:10.1016/S0079-6107(02)00037-8

61. McNeil E., C. T. Capaldo and I. G. Macara: Zonula occludens-1 function in the assembly of tight junctions in Madin-Darby canine kidney epithelial cells. Mol. Biol. Cell, 17, 1922-1932 (2006)
doi:10.1091/mbc.E05-07-0650

62. Umeda K., T. Matsui, M. Nakayama, K. Furuse, H. Sasaki, M. Furuse and S. Tsukita: Establishment and characterization of cultured epithelial cells lacking expression of ZO-1. J. Biol. Chem., 279, 44785-44794 (2004)
doi:10.1074/jbc.M406563200

63. Funke L., S. Dakoji and D. S. Bredt: Membrane-associated guanylate kinases regulate adhesion and plasticity at cell junctions. Annu Rev Biochem, 74, 219-45 (2005)
doi:10.1146/annurev.biochem.74.082803.133339

64. Itoh M, A. Nagafuchi, S. Moroi and S. Tsukita: Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J. Cell Biol., 138, 181-192 (1997)
doi:10.1083/jcb.138.1.181

65. Rajasekaran A. K., M. Hojo, T. Huima and E. Rodriguez-Boulan: Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. J Cell Biol, 132, 451-463 (1996)
doi:10.1083/jcb.132.3.451

66. Balda M. S. and K. Matter: The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J, 19, 2024-2033 (2000)
doi:10.1093/emboj/19.9.2024

67. Betanzos A., M. Huerta, E. Lopez-Bayghen, E. Azuara, J. Amerena and L. Gonzalez-Mariscal: The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res, 292, 51-66 (2004)
doi:10.1016/j.yexcr.2003.08.007

68. Gottardi C. J., M. Arpin, A. S. Fanning and D. Louvard: The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci U S A, 93, 10779-10784 (1996)
doi:10.1073/pnas.93.20.10779

69. Islas S., J. Vega, L. Ponce and L. Gonzalez-Mariscal: Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res, 274, 138-148 (2002)
doi:10.1006/excr.2001.5457

70. Jaramillo B. E., A. Ponce, J. Moreno, A. Betanzos, M. Huerta, E. Lopez-Bayghen and L. Gonzalez-Mariscal: Characterization of the tight junction protein ZO-2 localized at the nucleus of epithelial cells. Exp Cell Res, 297, 247-258 (2004)
doi:10.1016/j.yexcr.2004.03.021

71. Traweger A., R. Fuchs, I. A. Krizbai, T. M. Weiger, H. C. Bauer and H. Bauer: The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-B. J Biol Chem, 278, 2692-2700 (2003)
doi:10.1074/jbc.M206821200

72. Rajasekaran S. A., K. W. Beyenbach and A. K. Rajasekaran: Interactions of tight junctions with membrane channels and transporters. Biochim Biophys Acta, 1778, 757-769 (2008)
doi:10.1016/j.bbamem.2007.11.007

73. Crane R. K.: Comments and experiments on the kinetics of Na+ gradient-coupled glucose transport as found in rabbit jejunal brush-border membrane vesicles. Ann N Y Acad Sci, 456, 36-46 (1985)
doi:10.1111/j.1749-6632.1985.tb14842.x

74. Hoffmann E. K. and L. O. Simonsen: Membrane mechanisms in volume and pH regulation in vertebrate cells. Physiol Rev, 69, 315-382 (1989)

75. Schultz S. G. and P. F. Curran: Coupled transport of sodium and organic solutes. Physiol Rev, 50, 637-718 (1970)

76. Shull G. E., L. K. Lane and J. B. Lingrel: Amino-acid sequence of the beta-subunit of the (Na+ + K+)ATPase deduced from a cDNA. Nature, 321, 429-431. (1986)
doi:10.1038/321429a0

77. Shull G. E., A. Schwartz and J. B. Lingrel: Amino-acid sequence of the catalytic subunit of the (Na+ + K+)ATPase deduced from a complementary DNA. Nature, 316, 691695. (1985)
doi:10.1038/316691a0

78. Beguin P., X. Wang, D. Firsov, A. Puoti, D. Claeys, J. D. Horisberger and K. Geering: The gamma subunit is a specific component of the Na,K-ATPase and modulates its transport function. Embo J, 16, 4250-4260 (1997)
doi:10.1093/emboj/16.14.4250

79. Garty H. and S. J. Karlish: Role of FXYD proteins in ion transport. Annu Rev Physiol, 68, 431-459 (2006)
doi:10.1146/annurev.physiol.68.040104.131852

80. Geering K.: FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Renal Physiol, 290, F241-250 (2006)
doi:10.1152/ajprenal.00126.2005

81. Blanco G.: Na,K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation. Semin Nephrol, 25, 292-303 (2005)
doi:10.1016/j.semnephrol.2005.03.004

82. Pressley T. A., M. J. Duran and S. V. Pierre: Regions conferring isoform-specific function in the catalytic subunit of the Na,K-pump. Front Biosci, 10, 2018-2026 (2005)
doi:10.2741/1677

83. Keenan S. M., R. K. DeLisle, W. J. Welsh, S. Paula and W. J. Ball, Jr.: Elucidation of the Na+, K+-ATPase digitalis binding site. J Mol Graph Model, 23, 465-475 (2005)
doi:10.1016/j.jmgm.2005.02.001

84. Morth J. P., B. P. Pedersen, M. S. Toustrup-Jensen, T. L. Sorensen, J. Petersen, J. P. Andersen, B. Vilsen and P. Nissen: Crystal structure of the sodium-potassium pump. Nature, 450, 1043-1049 (2007)
doi:10.1038/nature06419

85. Gloor S., H. Antonicek, K. J. Sweadner, S. Pagliusi, R. Frank, M. Moos and M. Schachner: The adhesion molecule on glia (AMOG) is a homologue of the beta subunit of the Na,K-ATPase. J Cell Biol, 110, 165-174 (1990)
doi:10.1083/jcb.110.1.165

86. Good P. J., K. Richter and I. B. Dawid: A nervous system-specific isotype of the beta subunit of Na+,K (+)-ATPase expressed during early development of Xenopus laevis. Proc Natl Acad Sci U S A, 87, 9088-92 (1990)
doi:10.1073/pnas.87.23.9088

87. Miller R. P. and R. A. Farley: All three potential N-glycosylation sites of the dog kidney (Na+ + K+)-ATPase beta-subunit contain oligosaccharide. Biochim Biophys Acta, 954, 50-57 (1988)

88. Geering K.: The functional role of beta subunits in oligomeric P-type ATPases. J Bioenerg Biomembr, 33, 425-438 (2001)
doi:10.1023/A:1010623724749

89. Shoshani L., R. G. Contreras, M. L. Roldan, J. Moreno, A. Lazaro, M. S. Balda, K. Matter and M. Cereijido: The polarized expression of Na+,K+-ATPase in epithelia depends on the association between beta-subunits located in neighboring cells. Mol Biol Cell, 16, 1071-1081 (2005)
doi:10.1091/mbc.E04-03-0267

90. Vagin O., E. Tokhtaeva and G. Sachs: The role of the beta1 subunit of the Na,K-ATPase and its glycosylation in cell-cell adhesion. J Biol Chem, 281, 39573-39587 (2006)
doi:10.1074/jbc.M606507200

91. Lutsenko S. and J. H. Kaplan: An essential role for the extracellular domain of the Na,K-ATPase beta-subunit in cation occlusion. Biochemistry, 32, 6737-6743 (1993)
doi:10.1021/bi00077a029

92. Barwe S. P., S. Kim, S. A. Rajasekaran, J. U. Bowie and A. K. Rajasekaran: Janus model of the Na,K-ATPase beta-subunit transmembrane domain: distinct faces mediate alpha/beta assembly and beta-beta homo-oligomerization. J Mol Biol, 365, 706-714 (2007)
doi:10.1016/j.jmb.2006.10.029

93. Ivanov A. V., N. N. Modyanov and A. Askari: Role of the self-association of beta subunits in the oligomeric structure of Na+/K+-ATPase. Biochem J, 364, 293-299 (2002)

94. Mercer R. W., D. Biemesderfer, D. P. Bliss, Jr., J. H. Collins and B. Forbush, 3rd: Molecular cloning and immunological characterization of the gamma polypeptide, a small protein associated with the Na,K-ATPase. J Cell Biol, 121, 579-586 (1993)
doi:10.1083/jcb.121.3.579

95. Ino Y., M. Gotoh, M. Sakamoto, K. Tsukagoshi and S. Hirohashi: Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci U S A, 99, 365-370 (2002)
doi:10.1073/pnas.012425299

96. Nam J.-S., S. Hirohashi and L. M. Wakefield: Dysadherin: A new player in cancer progression. Cancer Letters, 255, 161-169 (2007)
doi:10.1016/j.canlet.2007.02.018

97. Mijatovic T., E. Van Quaquebeke, B. Delest, O. Debeir, F. Darro and R. Kiss: Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta, 1776, 32-57 (2007)

98. Therien A. G. and R. Blostein: Mechanisms of sodium pump regulation. Am J Physiol Cell Physiol, 279, C541-566 (2000)

99. Lecuona E., H. E. Trejo and J. I. Sznajder: Regulation of Na,K-ATPase during acute lung injury. J Bioenerg Biomembr, 39, 391-395 (2007)
doi:10.1007/s10863-007-9102-1

100. Lopina O. D.: Interaction of Na,K-ATPase catalytic subunit with cellular proteins and other endogenous regulators. Biochemistry (Mosc), 66, 1122-1131 (2001)
doi:10.1023/A:1012432913689

101. Bibert S., S. Roy, D. Schaer, J. D. Horisberger and K. Geering: Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na,K-ATPase isozymes. J Biol Chem, 283, 476-486 (2008)
doi:10.1074/jbc.M705830200

102. Devarajan P., D. A. Scaramuzzino and J. S. Morrow: Ankyrin binds to two distinct cytoplasmic domains of Na,K-ATPase alpha subunit. Proc Natl Acad Sci U S A, 91, 2965-2969 (1994)
doi:10.1073/pnas.91.8.2965

103. Nelson W. J. and P. J. Veshnock: Ankyrin binding to (Na+ + K+)ATPase and implications for the organization of membrane domains in polarized cells. Nature, 328, 533-536 (1987)
doi:10.1038/328533a0

104. Lee K., J. Jung, M. Kim and G. Guidotti: Interaction of the alpha subunit of Na,K-ATPase with cofilin. Biochem J, 353, 377-385 (2001)
doi:10.1042/0264-6021:3530377

105. Kimura T., P. B. Allen, A. C. Nairn and M. J. Caplan: Arrestins and spinophilin competitively regulate Na+,K+-ATPase trafficking through association with a large cytoplasmic loop of the Na+,K+-ATPase. Mol Biol Cell, 18, 4508-4518 (2007)
doi:10.1091/mbc.E06-08-0711

106. Ogimoto G., G. A. Yudowski, C. J. Barker, M. Kohler, A. I. Katz, E. Feraille, C. H. Pedemonte, P.-O. Berggren and A. M. Bertorello: G protein-coupled receptors regulate Na+,K+-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin. Proc Natl Acad Sci U S A, 97, 3242-3247 (2000)
doi:10.1073/pnas.060025597

107. Wang H., M. Haas, M. Liang, T. Cai, J. Tian, S. Li and Z. Xie: Ouabain assembles signaling cascades through the caveolar Na+/K+-ATPase. J. Biol. Chem., 279, 17250-17259 (2004)
doi:10.1074/jbc.M313239200

108. Zatti A, V. Chauvet, V. Rajendran, T. Kimura, P. Pagel and M. J. Caplan: The C-terminal tail of the polycystin-1 protein interacts with the Na,K-ATPase alpha-subunit. Mol Biol Cell, 16, 5087-5093 (2005)
doi:10.1091/mbc.E05-03-0200

109. Barwe S. P., G. Anilkumar, S. Y. Moon, Y. Zheng, J. P. Whitelegge, S. A. Rajasekaran and A. K. Rajasekaran: Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol Biol Cell, 16, 1082-1094 (2005)
doi:10.1091/mbc.E04-05-0427

110. Tian J., T. Cai, Z. Yuan, H. Wang, L. Liu, M. Haas, E. Maksimova, X. Y. Huang and Z. J. Xie: Binding of Src to Na+/K+-ATPase forms a functional signaling complex. Mol Biol Cell, 17, 317-326 (2006)
doi:10.1091/mbc.E05-08-0735

111. Yuan Z., T. Cai, J. Tian, A. V. Ivanov, D. R. Giovannucci and Z. Xie: Na/K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol Biol Cell, 16, 4034-4045 (2005)
doi:10.1091/mbc.E05-04-0295

112. Zatyka M., C. Ricketts, G. da Silva Xavier, J. Minton, S. Fenton, S. Hofmann-Thiel, G. A. Rutter and T. G. Barrett: Sodium-potassium ATPase 1 subunit is a molecular partner of Wolframin, an endoplasmic reticulum protein involved in ER stress. Hum Mol Genet, 17, 190-200 (2008)
doi:10.1093/hmg/ddm296

113. Molday L. L., W. W. Wu and R. S. Molday: Retinoschisin (RS1), the protein encoded by the X-linked retinoschisis gene, is anchored to the surface of retinal photoreceptor and bipolar cells through its interactions with a Na/K ATPase-SARM1 complex. J Biol Chem, 282, 32792-32801 (2007)
doi:10.1074/jbc.M706321200

114. Bhullar R. P., R. R. Clough, J. Kanungo, S. M. Elsaraj and O. Grujic: Ral-GTPase interacts with the beta1 subunit of Na+/K+-ATPase and is activated upon inhibition of the Na+/K+ pump. Can J Physiol Pharmacol, 85, 444-454 (2007)
doi:10.1139/Y07-027

115. Nakagawa Y., V. Rivera and A. C. Larner: A role for the Na/K-ATPase in the control of human c-fos and c-jun transcription. J Biol Chem, 267, 8785-8788 (1992)

116. Peng M., L. Huang, Z. Xie, W. H. Huang and A. Askari: Partial inhibition of Na+/K+-ATPase by ouabain induces the Ca2+-dependent expressions of early-response genes in cardiac myocytes. J Biol Chem, 271, 10372-10378 (1996)
doi:10.1074/jbc.271.17.10372

117. Kometiani P., J. Li, L. Gnudi, B. B. Kahn, A. Askari and Z. Xie: Multiple signal transduction pathways link Na+/K+-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases. J Biol Chem, 273, 15249-15256 (1998)
doi:10.1074/jbc.273.24.15249

118. Haas M., A. Askari and Z. Xie: Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J. Biol. Chem., 275, 27832-27837 (2000)

119. Haas M., H. Wang, J. Tian and Z. Xie: Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem, 277, 18694-18702 (2002)
doi:10.1074/jbc.M111357200

120. Pierre S. V. and Z. Xie: The Na,K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys, 46, 303-36 (2006)
doi:10.1385/CBB:46:3:303

121. Liu J., R. Kesiry, S. M. Periyasamy, D. Malhotra, Z. Xie and J. I. Shapiro: Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int, 66, 227-241 (2004)
doi:10.1111/j.1523-1755.2004.00723.x

122. Zhou X., G. Jiang, A. Zhao, T. Bondeva, P. Hirszel and T. Balla: Inhibition of Na,K-ATPase activates PI3 kinase and inhibits apoptosis in LLC-PK1 cells. Biochem Biophys Res Commun, 285, 46-51 (2001)
doi:10.1006/bbrc.2001.5126

123. Rajasekaran S. A., L. G. Palmer, S. Y. Moon, A. Peralta Soler, G. L. Apodaca, J. F. Harper, Y. Zheng and A. K. Rajasekaran: Na,K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Mol Biol Cell, 12, 3717-3732 (2001)

124. Dostanic I., J. Schultz Jel, J. N. Lorenz and J. B. Lingrel: The alpha 1 isoform of Na,K-ATPase regulates cardiac contractility and functionally interacts and co-localizes with the Na/Ca exchanger in heart. J Biol Chem, 279, 54053-54061 (2004)
doi:10.1074/jbc.M410737200

125. Tian J., X. Gong and Z. Xie: Signal-transducing function of Na+-K+-ATPase is essential for ouabain's effect on (Ca2+)i in rat cardiac myocytes. Am J Physiol Heart Circ Physiol, 281, H1899-1907 (2001)

126. Xie Z., P. Kometiani, J. Liu, J. Li, J. I. Shapiro and A. Askari: Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem, 274, 19323-19328 (1999)
doi:10.1074/jbc.274.27.19323

127. Oweis S., L. Wu, P. R. Kiela, H. Zhao, D. Malhotra, F. K. Ghishan, Z. Xie, J. I. Shapiro and J. Liu: Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells. Am J Physiol Renal Physiol, 290, F997-1008 (2006)
doi:10.1152/ajprenal.00322.2005

128. Cai H., L. Wu, W. Qu, D. Malhotra, Z. Xie, J. I. Shapiro and J. Liu: Regulation of apical NHE3 trafficking by ouabain-induced activation of the basolateral Na+-K+-ATPase receptor complex. Am J Physiol Cell Physiol, 294, C555-563 (2008)
doi:10.1152/ajpcell.00475.2007

129. Rajasekaran S. A., L. G. Palmer, K. Quan, J. F. Harper, W. J. Ball, Jr., N. H. Bander, A. Peralta Soler and A. K. Rajasekaran: Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Biol Cell, 12, 279-295 (2001)

130. Behrens J., M. M. Mareel, F. M. Van Roy and W. Birchmeier: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol., 108, 2435-2447 (1989)
doi:10.1083/jcb.108.6.2435

131. Rajasekaran S. A., J. Hu, J. Gopal, R. Gallemore, S. Ryazantsev, D. Bok and A. K. Rajasekaran: Na,K-ATPase inhibition alters tight junction structure and permeability in human retinal pigment epithelial cells. Am J Physiol Cell Physiol, 284, C1497-1507 (2003)

132. Jou T.-S., E. E. Schneeberger and W. James Nelson: Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases. J. Cell Biol., 142, 101-115 (1998)
doi:10.1083/jcb.142.1.101

133. Nusrat A., M. Giry, J. R. Turner, S. P. Colgan, C. A. Parkos, D. Carnes, E. Lemichez, P. Boquet and J. L. Madara: Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc Natl Acad Sci U S A, 92, 10629-10633 (1995)
doi:10.1073/pnas.92.23.10629

134. Takaishi K., T. Sasaki, H. Kotani, H. Nishioka and Y. Takai: Regulation of cell-cell adhesion by Rac and Rho Small G proteins in MDCK Cells. J. Cell Biol., 139, 1047-1059 (1997)
doi:10.1083/jcb.139.4.1047

135. Rajasekaran A. K. and S. A. Rajasekaran: Role of Na-K-ATPase in the assembly of tight junctions. Am J Physiol Renal Physiol, 285, F388-396 (2003)

136. Biggers J. D., J. E. Bell and D. J. Benos: Mammalian blastocyst: transport functions in a developing epithelium. Am J Physiol, 255, C419-432 (1988)

137. Wiley L.: Development of the blastocyst: role of cell polarity in cavitation and cell differentiation. In: The Mammalian Preimplantation Embryo: Regulation of Growth and Differentiation in vitro. Ed B. Bavister. Plenum Publishing Co., New York (1987)

138. Vestweber D., A. Gossler, K. Boller and R. Kemler: Expression and distribution of cell adhesion molecule uvomorulin in mouse preimplantation embryos. Dev Biol, 124, 451-456 (1987)
doi:10.1016/0012-1606(87)90498-2

139. Watson A. J., D. R. Natale and L. C. Barcroft: Molecular regulation of blastocyst formation. Anim Reprod Sci, 82-83, 583-592 (2004)
doi:10.1016/j.anireprosci.2004.04.004

140. Moriwaki K., S. Tsukita and M. Furuse: Tight junctions containing claudin 4 and 6 are essential for blastocyst formation in preimplantation mouse embryos. Dev Biol, 312, 509-522 (2007)

141. Watson A. J. and L. C. Barcroft: Regulation of blastocyst formation. Front Biosci, 6, D708-730 (2001)
doi:10.2741/Watson

142. Barcroft L. C., A. E. Moseley, J. B. Lingrel and A. J. Watson: Deletion of the Na/K-ATPase alpha1-subunit gene (Atp1a1) does not prevent cavitation of the preimplantation mouse embryo. Mech Dev, 121, 417-426 (2004)

143. Violette M. I., P. Madan and A. J. Watson: Na+/K+ -ATPase regulates tight junction formation and function during mouse preimplantation development. Dev Biol, 289, 406-419 (2006)
doi:10.1016/j.ydbio.2005.11.004

144. Madan P., K. Rose and A. J. Watson: Na/K-ATPase beta1 subunit expression is required for blastocyst formation and normal assembly of trophectoderm tight junction-associated proteins. J Biol Chem, 282, 12127-12134 (2007)
doi:10.1074/jbc.M700696200

145. Eckert J. J., A. McCallum, A. Mears, M. G. Rumsby, I. T. Cameron and T. P. Fleming: Specific PKC isoforms regulate blastocoel formation during mouse preimplantation development. Dev Biol, 274, 384-401 (2004)
doi:10.1016/j.ydbio.2004.07.027

146. Blasiole B., V. Canfield, A. Degrave, C. Thisse, B. Thisse, J. Rajarao and R. Levenson: Cloning, mapping, and developmental expression of a sixth zebrafish Na,K-ATPase alpha1 subunit gene (atp1a1a.5). Mech Dev, 119 Suppl 1, S211-214 (2002)
doi:10.1016/S0925-4773(03)00118-7

147. Blasiole B., V. A. Canfield, M. A. Vollrath, D. Huss, M. A. Mohideen, J. D. Dickman, K. C. Cheng, D. M. Fekete and R. Levenson: Separate Na,K-ATPase genes are required for otolith formation and semicircular canal development in zebrafish. Dev Biol, 294, 148-160 (2006)
doi:10.1016/j.ydbio.2006.02.034

148. Rajarao J. R., V. A. Canfield, B. Loppin, B. Thisse, C. Thisse, Y. L. Yan, J. H. Postlethwait and R. Levenson: Two Na,K-ATPase beta 2 subunit isoforms are differentially expressed within the central nervous system and sensory organs during zebrafish embryogenesis. Dev Dyn, 223, 254-261 (2002)
doi:10.1002/dvdy.10045

149. Rajarao S. J., V. A. Canfield, M. A. Mohideen, Y. L. Yan, J. H. Postlethwait, K. C. Cheng and R. Levenson: The repertoire of Na,K-ATPase alpha and beta subunit genes expressed in the zebrafish, Danio rerio. Genome Res, 11, 1211-1220 (2001)
doi:10.1101/gr.186001

150. Stainier D. Y. and M. C. Fishman: Patterning the zebrafish heart tube: acquisition of anteroposterior polarity. Dev Biol, 153, 91-101 (1992)
doi:10.1016/0012-1606(92)90094-W

151. Yelon D.: Cardiac patterning and morphogenesis in zebrafish. Dev Dyn, 222, 552-563 (2001)
doi:10.1002/dvdy.1243

152. Yelon D., S. A. Horne and D. Y. Stainier: Restricted expression of cardiac myosin genes reveals regulated aspects of heart tube assembly in zebrafish. Dev Biol, 214, 23-37 (1999)
doi:10.1006/dbio.1999.9406

153. Shu X., K. Cheng, N. Patel, F. Chen, E. Joseph, H. J. Tsai and J. N. Chen: Na,K-ATPase is essential for embryonic heart development in the zebrafish. Development, 130, 6165-6173 (2003)
doi:10.1242/dev.00844

154. Cibrian-Uhalte E., A. Langenbacher, X. Shu, J. N. Chen and S. Abdelilah-Seyfried: Involvement of zebrafish Na+,K+ ATPase in myocardial cell junction maintenance. J Cell Biol, 176, 223-230 (2007)
doi:10.1083/jcb.200606116

155. Horne-Badovinac S., D. Lin, S. Waldron, M. Schwarz, G. Mbamalu, T. Pawson, Y. Jan, D. Y. Stainier and S. Abdelilah-Seyfried: Positional cloning of heart and soul reveals multiple roles for PKC lambda in zebrafish organogenesis. Curr Biol, 11, 1492-1502 (2001)
doi:10.1016/S0960-9822(01)00458-4

156. Peterson R. T., J. D. Mably, J. N. Chen and M. C. Fishman: Convergence of distinct pathways to heart patterning revealed by the small molecule concentramide and the mutation heart-and-soul. Curr Biol, 11, 1481-1491 (2001)
doi:10.1016/S0960-9822(01)00482-1

157. Rohr S., N. Bit-Avragim and S. Abdelilah-Seyfried: Heart and soul/PRKCi and nagie oko/Mpp5 regulate myocardial coherence and remodeling during cardiac morphogenesis. Development, 133, 107-115 (2006)
doi:10.1242/dev.02182

158. Bagnat M., I. D. Cheung, K. E. Mostov and D. Y. Stainier: Genetic control of single lumen formation in the zebrafish gut. Nat Cell Biol, 9, 954-960 (2007)
doi:10.1038/ncb1621

159. Bradley T. J., A. M. Stuart and P. Satir: The ultrastructure of the larval malpighian tubules of a saline-water mosquito. Tissue Cell, 14, 759-773 (1982)
doi:10.1016/0040-8166(82)90064-7

160. Wu V. M. and G. J. Beitel: A junctional problem of apical proportions: epithelial tube-size control by septate junctions in the Drosophila tracheal system. Curr Opin Cell Biol, 16, 493-499 (2004)
doi:10.1016/j.ceb.2004.07.008

161. Genova J. L. and R. G. Fehon: Neuroglian, Gliotactin, and the Na+/K+ ATPase are essential for septate junction function in Drosophila. J Cell Biol, 161, 979-989 (2003)
doi:10.1083/jcb.200212054

162. Paul S. M., M. J. Palladino and G. J. Beitel: A pump-independent function of the Na,K-ATPase is required for epithelial junction function and tracheal tube-size control. Development, 134, 147-155 (2007)
doi:10.1242/dev.02710

163. Paul S. M., M. Ternet, P. M. Salvaterra and G. J. Beitel: The Na+/K+ ATPase is required for septate junction function and epithelial tube-size control in the Drosophila tracheal system. Development, 130, 4963-4974 (2003)
doi:10.1242/dev.00691

164. Palladino M. J., J. E. Bower, R. Kreber and B. Ganetzky: Neural dysfunction and neurodegeneration in Drosophila Na+/K+ ATPase alpha subunit mutants. J Neurosci, 23, 1276-1286 (2003)

165. Vogelmann R. and W. J. Nelson: Fractionation of the epithelial apical junctional complex: reassessment of protein distributions in different substructures. Mol Biol Cell, 16, 701-716 (2005)
doi:10.1091/mbc.E04-09-0827

166. Lee D. B., N. Jamgotchian, S. G. Allen, F. W. Kan and I. L. Hale: Annexin A2 heterotetramer: role in tight junction assembly. Am J Physiol Renal Physiol, 287, F481-491 (2004)
doi:10.1152/ajprenal.00175.2003

167. Colosetti P., R. E. Tunwell, C. Cruttwell, J. P. Arsanto, J. P. Mauger and D. Cassio: The type 3 inositol 1,4,5-trisphosphate receptor is concentrated at the tight junction level in polarized MDCK cells. J Cell Sci, 116, 2791-2803 (2003)
doi:10.1242/jcs.00482

168. Frankel P., A. Aronheim, E. Kavanagh, M. S. Balda, K. Matter, T. D. Bunney and C. J. Marshall: RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity. EMBO J, 24, 54-62 (2005)
doi:10.1038/sj.emboj.7600497

169. Vagin O., E. Tokhtaeva, I. Yakubov, E. Shevchenko and G. Sachs: Inverse correlation between the extent of N-glycan branching and intercellular adhesion in epithelia. Contribution of the Na,K-ATPase beta1 subunit. J Biol Chem, 283, 2192-2202 (2008)
doi:10.1074/jbc.M704713200

170. Antonicek H., E. Persohn and M. Schachner: Biochemical and functional characterization of a novel neuron-glia adhesion molecule that is involved in neuronal migration. J Cell Biol, 104, 1587-1595 (1987)
doi:10.1083/jcb.104.6.1587

171. Treuheit M. J., C. E. Costello and T. L. Kirley: Structures of the complex glycans found on the beta-subunit of (Na,K)-ATPase. J Biol Chem, 268, 13914-13919 (1993)

172. Kitamura N., M. Ikekita, T. Sato, Y. Akimoto, Y. Hatanaka, H. Kawakami, M. Inomata and K. Furukawa: Mouse Na+/K+-ATPase beta1-subunit has a K+-dependent cell adhesion activity for beta-GlcNAc-terminating glycans. Proc Natl Acad Sci U S A, 102, 2796-2801 (2005)
doi:10.1073/pnas.0409344102

173. Vagin O., G. Sachs and E. Tokhtaeva: The roles of the Na,K-ATPase beta 1 subunit in pump sorting and epithelial integrity. J Bioenerg Biomembr, 39, 367-372 (2007)
doi:10.1007/s10863-007-9103-0

174. Liang M., J. Tian, L. Liu, S. Pierre, J. Liu, J. Shapiro and Z. J. Xie: Identification of a pool of non-pumping Na/K-ATPase. J Biol Chem, 282, 10585-10593 (2007)
doi:10.1074/jbc.M609181200

175. Xie Z. and T. Cai: Na+-K+--ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv, 3, 157-168 (2003)
doi:10.1124/mi.3.3.157

176. Ridley A. J. and A. Hall: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell, 70, 389-399 (1992)
doi:10.1016/0092-8674(92)90163-7

177. Meyer T. N., J. Hunt, C. Schwesinger and B. M. Denker: Galpha12 regulates epithelial cell junctions through Src tyrosine kinases. Am J Physiol Cell Physiol, 285, C1281-1293 (2003)

178. Sabath E., H. Negoro, S. Beaudry, M. Paniagua, S. Angelow, J. Shah, N. Grammatikakis, A. S. Yu and B. M. Denker: G{alpha}12 regulates protein interactions within the MDCK cell tight junction and inhibits tight-junction assembly. J Cell Sci, 814-824 (2008)
doi:10.1242/jcs.014878

179. Basuroy S., P. Sheth, D. Kuppuswamy, S. Balasubramanian, R. M. Ray and R. K. Rao: Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem, 278, 11916-11924 (2003)
doi:10.1074/jbc.M211710200

180. Chen Y., Q. Lu, E. E. Schneeberger and D. A. Goodenough: Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell, 11, 849-862 (2000)

181. Wang Y., J. Zhang, X. J. Yi and F. S. Yu: Activation of ERK1/2 MAP kinase pathway induces tight junction disruption in human corneal epithelial cells. Exp Eye Res, 78, 125-136 (2004)
doi:10.1016/j.exer.2003.09.002

182. Basuroy S., A. Seth, B. Elias, A. P. Naren and R. Rao: MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem J, 393, 69-77 (2006)
doi:10.1042/BJ20050959

183. Wang Y., D. Du, L. Fang, G. Yang, C. Zhang, R. Zeng, A. Ullrich, F. Lottspeich and Z. Chen: Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling. EMBO J, 25, 5058-5070 (2006)
doi:10.1038/sj.emboj.7601384

184. Wattenberg E. V., K. L. Byron, M. L. Villereal, H. Fujiki and M. R. Rosner: Sodium as a mediator of non-phorbol tumor promoter action. Down-modulation of the epidermal growth factor receptor by palytoxin. J Biol Chem, 264, 14668-14673 (1989)

185. Wattenberg E. V., P. L. McNeil, H. Fujiki and M. R. Rosner: Palytoxin down-modulates the epidermal growth factor receptor through a sodium-dependent pathway. J Biol Chem, 264, 213-219 (1989)

186. Artigas P. and D. C. Gadsby: Na+/K+-pump ligands modulate gating of palytoxin-induced ion channels. Proc Natl Acad Sci U S A, 100, 501-505 (2003)
doi:10.1073/pnas.0135849100

187. Artigas P. and D. C. Gadsby: Large diameter of palytoxin-induced Na/K pump channels and modulation of palytoxin interaction by Na/K pump ligands. J Gen Physiol, 123, 357-376 (2004)
doi:10.1085/jgp.200308964

188. Lezama R., A. Diaz-Tellez, G. Ramos-Mandujano, L. Oropeza and H. Pasantes-Morales: Epidermal growth factor receptor is a common element in the signaling pathways activated by cell volume changes in isosmotic, hyposmotic or hyperosmotic conditions. Neurochem Res, 30, 1589-1597 (2005)
doi:10.1007/s11064-005-8837-5

189. Barwe S. P., S. A. Rajasekaran and A. K. Rajasekaran: Identification of protein kinase C as an intermediate in Na,K-ATPase beta-subunit mediated lamellipodia formation and suppression of cell motility in carcinoma cells. Cell Mol Biol, 52, 41-47 (2006)

190. Rajasekaran S. A., S. P. Barwe and A. K. Rajasekaran: Multiple functions of Na,K-ATPase in epithelial cells. Semin Nephrol, 25, 328-334 (2005)
doi:10.1016/j.semnephrol.2005.03.008

191. Sugi K., M. W. Musch, M. Field and E. B. Chang: Inhibition of Na+,K+-ATPase by interferon gamma down-regulates intestinal epithelial transport and barrier function. Gastroenterology, 120, 1393-1403 (2001)
doi:10.1053/gast.2001.24045

192. Ohkubo T. and M. Ozawa: The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci, 117, 1675-1685 (2004)
doi:10.1242/jcs.01004

193. Wang Z., P. Wade, K. J. Mandell, A. Akyildiz, C. A. Parkos, R. J. Mrsny and A. Nusrat: Raf 1 represses expression of the tight junction protein occludin via activation of the zinc-finger transcription factor slug. Oncogene, 26, 1222-1230 (2007)
doi:10.1038/sj.onc.1209902

194. Whiteman E. L., C. J. Liu, E. R. Fearon and B. Margolis: The transcription factor snail represses Crumbs3 expression and disrupts apico-basal polarity complexes. Oncogene (2008)

195. Espineda C. E., J. H. Chang, J. Twiss, S. A. Rajasekaran and A. K. Rajasekaran: Repression of Na,K-ATPase beta1-subunit by the transcription factor snail in carcinoma. Mol Biol Cell, 15, 1364-1373 (2004)
doi:10.1091/mbc.E03-09-0646

196. Madara J. L. and J. R. Pappenheimer: Structural basis for physiological regulation of paracellular pathways in intestinal epithelia. J Membr Biol, 100, 149-164 (1987)
doi:10.1007/BF02209147

197. Turner J. R., D. E. Cohen, R. J. Mrsny and J. L. Madara: Noninvasive in vivo analysis of human small intestinal paracellular absorption: regulation by Na+-glucose cotransport. Dig Dis Sci, 45, 2122-2126 (2000)
doi:10.1023/A:1026682900586

198. Turner J. R., B. K. Rill, S. L. Carlson, D. Carnes, R. Kerner, R. J. Mrsny and J. L. Madara: Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol, 273, C1378-1385 (1997)

199. Turner J. R., E. D. Black, J. Ward, C. M. Tse, F. A. Uchwat, H. A. Alli, M. Donowitz, J. L. Madara and J. M. Angle: Transepithelial resistance can be regulated by the intestinal brush-border Na (+)/H (+) exchanger NHE3. Am J Physiol Cell Physiol, 279, C1918-1924 (2000)

200. Kim G., S. A. Rajasekaran, G. Thomas, E. A. Rosen, E. M. Landaw, P. Shintaku, C. Lassman, J. Said and A. K. Rajasekaran: Renal clear-cell carcinoma: an ultrastructural study on the junctional complexes. Histol Histopathol, 20, 35-44 (2005)

201. Kaplan J. G.: Membrane cation transport and the control of proliferation of mammalian cells. Annu Rev Physiol, 40, 19-41 (1978)
doi:10.1146/annurev.ph.40.030178.000315

202. Shen S. S., S. T. Hamamoto, H. A. Bern and R. A. Steinhardt: Alteration of sodium transport in mouse mammary epithelium associated with neoplastic transformation. Cancer Res, 38, 1356-61 (1978)

203. Weidemann H.: Na/K-ATPase, endogenous digitalis like compounds and cancer development -- a hypothesis. Front Biosci, 10, 2165-76 (2005)
doi:10.2741/1688

204. Davies R. J., G. I. Sandle and S. M. Thompson: Inhibition of the Na+,K (+)-ATPase pump during induction of experimental colon cancer. Cancer Biochem Biophys, 12, 81-94 (1991)

205. Gonta-Grabiec K., W. Rossowski and I. Szumiel: Properties of Na+/K+ ATPase and alkaline phosphatase alter during spontaneous and radiation-induced leukemogenesis in mice. Neoplasma, 33, 141-155 (1986)

206. Rajasekaran S. A., W. J. Ball, Jr., N. H. Bander, H. Liu, J. D. Pardee and A. K. Rajasekaran: Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. J Urol, 162, 574-580 (1999)
doi:10.1016/S0022-5347(05)68629-6

207. Seligson D. B., S. A. Rajasekaran, H. Yu, X. Liu, M. Eeva, S. Tze, W. Ball, Jr., S. Horvath, J. B. deKernion and A. K. Rajasekaran: Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma. J Urol, 179, 338-345 (2008)
doi:10.1016/j.juro.2007.08.094

208. Sakai H., T. Suzuki, M. Maeda, Y. Takahashi, N. Horikawa, T. Minamimura, K. Tsukada and N. Takeguchi: Up-regulation of Na (+),K (+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer. FEBS Lett, 563, 151-154 (2004)
doi:10.1016/S0014-5793(04)00292-3

209. Blok L. J., G. T. Chang, M. Steenbeek-Slotboom, W. M. van Weerden, H. G. Swarts, J. J. De Pont, G. J. van Steenbrugge and A. O. Brinkmann: Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer. Br J Cancer, 81, 28-36 (1999)
doi:10.1038/sj.bjc.6690647

210. Mobasheri A., R. Fox, I. Evans, F. Cullingham, P. Martin-Vasallo and C. S. Foster: Epithelial Na, K-ATPase expression is down-regulated in canine prostate cancer; a possible consequence of metabolic transformation in the process of prostate malignancy. Cancer Cell Int, 3, 8 (2003)
doi:10.1186/1475-2867-3-8

211. Akopyanz N. S., N. E. Broude, E. P. Bekman, E. O. Marzen and E. D. Sverdlov: Tissue-specific expression of Na,K-ATPase beta-subunit. Does beta 2 expression correlate with tumorigenesis? FEBS Lett, 289, 8-10 (1991)
doi:10.1016/0014-5793(91)80896-B

212. Mijatovic T., I. Roland, E. Van Quaquebeke, B. Nilsson, A. Mathieu, F. Van Vynckt, F. Darro, G. Blanco, V. Facchini and R. Kiss: The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J Pathol, 212, 170-179 (2007)
doi:10.1002/path.2172

213. Espineda C., D. B. Seligson, W. James Ball, Jr., J. Rao, A. Palotie, S. Horvath, Y. Huang, T. Shi and A. K. Rajasekaran: Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer, 97, 1859-1868 (2003)
doi:10.1002/cncr.11267

214. Boukerche H., Z. Z. Su, D. C. Kang and P. B. Fisher: Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization. Gene, 343, 191-201 (2004)
doi:10.1016/j.gene.2004.09.002

215. Geering K.: Function of FXYD proteins, regulators of Na, K-ATPase. J Bioenerg Biomembr, 37, 387-392 (2005)
doi:10.1007/s10863-005-9476-x

216. Meij I. C., J. B. Koenderink, H. van Bokhoven, K. F. Assink, W. T. Groenestege, J. J. de Pont, R. J. Bindels, L. A. Monnens, L. P. van den Heuvel and N. V. Knoers: Dominant isolated renal magnesium loss is caused by misrouting of the Na (+),K (+)-ATPase gamma-subunit. Nat Genet, 26, 265-266 (2000)
doi:10.1038/81543

217. Simon D. B., Y. Lu, K. A. Choate, H. Velazquez, E. Al-Sabban, M. Praga, G. Casari, A. Bettinelli, G. Colussi, J. Rodriguez-Soriano, D. McCredie, D. Milford, S. Sanjad and R. P. Lifton: Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science, 285, 103-106 (1999)
doi:10.1126/science.285.5424.103

218. Allgayer H., W. Kruis, G. Paumgartner, B. Wiebecke, L. Brown and E. Erdmann: Inverse relationship between colonic (Na+ + K+)-ATPase activity and degree of mucosal inflammation in inflammatory bowel disease. Dig Dis Sci, 33, 417-422 (1988)
doi:10.1007/BF01536025

219. Ejderhamn J., Y. Finkel and B. Strandvik: Na,K-ATPase activity in rectal mucosa of children with ulcerative colitis and Crohn's disease. Scand J Gastroenterol, 24, 1121-1125 (1989)
doi:10.3109/00365528909089265

220. Rachmilewitz D., F. Karmeli and P. Sharon: Decreased colonic Na-K-ATPase activity in active ulcerative colitis. Isr J Med Sci, 20, 681-684 (1984)

221. Musch M. W., L. L. Clarke, D. Mamah, L. R. Gawenis, Z. Zhang, W. Ellsworth, D. Shalowitz, N. Mittal, P. Efthimiou, Z. Alnadjim, S. D. Hurst, E. B. Chang and T. A. Barrett: T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase. J Clin Invest, 110, 1739-1747 (2002)

Abbreviations: TJ: tight junction; SJ: septate junction; ZO: zonula occludens; MUPP: multi-PDZ protein; IFN: interferon; MDCK: Madin-Darby canine kidney; EGFR: epidermal growth factor receptor; TER: transepithelilal electrical resistance; HGF: hepatocyte growth factor; TGF: transforming growth factor; EMT: epithelial to mesenchymal transition; HNF: hepatocyte nuclear factor; CK: casein kinase; aPKC: atypical protein kinase C; PP2A: protein phosphatase 2A; VEGF: vascular endothelial growth factor; PI3: phosphatidyl-inositol 3; TNF: tumor necrosis factor; JAM: junctional adhesion molecule; MAGUK: membrane-associated guanylate kinase; ZONAB: ZO-1 associated nucleic acid binding; PKA: cAMP-dependent protein kinase A; PKG: cGMP-dependent protein kinase; PKC: Ca-phospholipid-dependent protein kinase; MAPK, mitogen-activated protein kinase; ROS: reactive oxygen species; MSV: Maloney sarcoma virus

Key Words: Na,K-ATPase, alpha-subunit, beta-subunit, Tight Junction, polarity, FXYD, Occludin, Signaling, Review

Send correspondence to: Sigrid A. Rajasekaran, Nemours Center for Childhood Cancer Research, Alfred I. DuPont Hospital for Children, Wilmington, DE 19803, Tel: 302-651-6538, Fax: 302-651-4827, E-mail:sraj@medsci.udel.edu